£4.7M
The funding round was co-led by KHP Ventures and Cedars-Sinai Intellectual Property Co.
52North develops diagnostic tools and digital platforms to transform urgent care pathways in oncology.
52North is a medical technology company focused on transforming urgent care pathways in oncology through accessible patient solutions. The Cambridge-based firm develops innovative diagnostic tools designed to improve health equity and patient safety.
Umaima Ahmad
CEO
The funding round was co-led by KHP Ventures and Cedars-Sinai Intellectual Property Co.